Aug 22 (Reuters) - Ambu A/S AMBUb.CO:
Q3 REVENUE DKK 1,507 MILLION VERSUS DKK 1,383 MILLION YEAR AGO
Q3 EBIT BEFORE SPECIAL ITEMS DKK 170 MILLION VERSUS DKK 178 MILLION YEAR AGO
FINANCIAL GUIDANCE FOR ORGANIC REVENUE GROWTH FOR 2024/25 IS UPDATED TO REFLECT CONTINUED SOLID GROWTH, NOW EXPECTED TO BE 12-14% (PREVIOUSLY 11-14%)
AMBU’S ENDOSCOPY SOLUTIONS BUSINESS CONTINUED TO BE BIGGEST REVENUE CONTRIBUTOR IN Q3
EXPERIENCED GROWTH ACROSS BOTH BUSINESS GROUPS IN ENDOSCOPY SOLUTIONS, MAINLY DRIVEN BY CONTINUED GROWTH OF EXISTING SOLUTIONS IN HIGH-GROWTH MARKET, WITH EXISTING AND NEW CUSTOMERS
Source text: [ID:]
Further company coverage: AMBUb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))